FDA Recalls Generic Adderall XR, Levothyroxine, Gas-X, and Moringa Supplements
Nationwide FDA recalls include generic Adderall XR (mix-up), levothyroxine (subpotent), Gas-X (coolant contamination), and several prescription drugs classed as Class II. Moringa dietary supplements are under Class I recall due to serious health risks. Consumers are advised to check lot numbers and consult pharmacists.
The U.S. Food and Drug Administration has announced several nationwide recalls affecting a range of prescription and over-the-counter medications, including generic Adderall XR, levothyroxine, and Gas-X, as well as multiple brands of moringa dietary supplements.
Most of the drug recalls are classified as Class II, meaning they may cause temporary or medically reversible adverse health consequences. The moringa supplement recalls are Class I, indicating a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
The prescription and over-the-counter drugs recalled include:
- Cinacalcet (Class II)
- Dextroamphetamine Saccharate/Amphetamine Aspartate Monohydrate/Dextroamphetamine Sulfate/Amphetamine Sulfate, the generic form of Adderall XR (Class II) – due to a mix-up
- Levothyroxine (Class II) – due to subpotency
- Glucagon Emergency Kit for low blood sugar (not yet classified)
- Amlodipine and Olmesartan Medoxomil (Class II)
- Duloxetine, the generic of Cymbalta (Class II)
- Epinephrine (Class II)
- Erythromycin (Class II)
- Estradiol (Class II)
- Gas-X (Class II) and Gas-X Extra Strength (not yet classified) – contamination with coolant
- Liraglutide (Class II)
The dietary supplements under Class I recall are:
- Organic Moringa Leaf Powder and Organic Moringa Leaf Capsules
- TNVitamins Ultrapotent Complete Green Superfood Moringa Capsules and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa Capsules
Consumers may check the linked enforcement reports for affected lot numbers and expiration dates. For prescription drugs without a lot number on the package, patients can consult their pharmacist to determine if their medication is included in the recall.